Literature DB >> 32725250

Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study.

Iris González-Villanueva1, Cristina DeGracia, Mariana Planells, Inés Poveda, Pedro Álvarez, Luca Schneller-Pavalescu, Isabel Betlloch, Gregor B E Jemec, Jose M Ramos, Jose C Pascual.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of end-stage liver disease. The aim of this controlled cross-sectional study was to assess the association between NAFLD and hidradenitis suppurativa. NAFLD was assessed using hepatic ultrasound. A total of 125 patients with hidradenitis suppurativa and 120 patients without hidradenitis suppurativa were recruited, matched for age, sex and body mass index (< 25 or ≥ 25 kg/m2), a risk factor related to NAFLD. Both groups presented similar proportions of overweight or obesity (89.6% vs 90%). Patients with hidradenitis suppurativa presented significantly higher prevalence of NAFLD compared with those with non- hidradenitis suppurativa (57.6% vs 31.7%, p < 0.001). Multivariable analysis confirmed independent association between hidradenitis suppurativa and NAFLD (odds ratio 2.79, 95% confidence interval 1.48-5.25; p = 0.001) besides age, body mass index, hypertension and hypertransaminasaemia. Hidradenitis suppurativa is significantly associated with the development of NALFD regardless of the presence of classic metabolic risk factors.

Entities:  

Keywords:  acne inversa; hepatic ultrasound; hidradenitis suppurativa; liver steatosis; non-alcoholic fatty liver disease

Mesh:

Year:  2020        PMID: 32725250      PMCID: PMC9207634          DOI: 10.2340/00015555-3597

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  41 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Clinical practice. Hidradenitis suppurativa.

Authors:  Gregor B E Jemec
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

3.  High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors.

Authors:  C Durán-Vian; M T Arias-Loste; J L Hernández; V Fernández; M González; P Iruzubieta; L Rasines; C González-Vela; J P Vaqué; R Blanco; J Crespo; M A González-López
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-07-22       Impact factor: 6.166

4.  Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.

Authors:  H H van der Zee; L de Ruiter; D G van den Broecke; W A Dik; J D Laman; E P Prens
Journal:  Br J Dermatol       Date:  2011-05-17       Impact factor: 9.302

Review 5.  Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.

Authors:  R Candia; A Ruiz; R Torres-Robles; N Chávez-Tapia; N Méndez-Sánchez; M Arrese
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-11-21       Impact factor: 6.166

Review 6.  Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.

Authors:  Enoch Cobbina; Fatemeh Akhlaghi
Journal:  Drug Metab Rev       Date:  2017-03-17       Impact factor: 4.518

7.  Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.

Authors:  Jean E Revuz; Florence Canoui-Poitrine; Pierre Wolkenstein; Cedric Viallette; Germaine Gabison; Florence Pouget; Florence Poli; Ousmane Faye; Jean Claude Roujeau; Genevieve Bonnelye; Jean Jacques Grob; Sylvie Bastuji-Garin
Journal:  J Am Acad Dermatol       Date:  2008-10       Impact factor: 11.527

8.  Insulin resistance in hidradenitis suppurativa: a case-control study.

Authors:  I Vilanova; J L Hernández; C Mata; C Durán; M T García-Unzueta; V Portilla; P Fuentevilla; A Corrales; M C González-Vela; M A González-Gay; R Blanco; M A González-López
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-03-23       Impact factor: 6.166

Review 9.  Non-invasive imaging techniques in assessing non-alcoholic fatty liver disease: a current status of available methods.

Authors:  A M Lăpădat; I R Jianu; B S Ungureanu; L M Florescu; D I Gheonea; S Sovaila; I A Gheonea
Journal:  J Med Life       Date:  2017 Jan-Mar

10.  The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis.

Authors:  Alexandra B Kimball; Murali Sundaram; Genevieve Gauthier; Annie Guérin; Irina Pivneva; Rakesh Singh; Arijit Ganguli
Journal:  Dermatol Ther (Heidelb)       Date:  2018-10-10
View more
  2 in total

Review 1.  NAFLD and Infection, a Nuanced Relationship.

Authors:  Abimbola Adenote; Igor Dumic; Cristian Madrid; Christopher Barusya; Charles W Nordstrom; Libardo Rueda Prada
Journal:  Can J Gastroenterol Hepatol       Date:  2021-04-15

Review 2.  Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?

Authors:  Katrin Witte; Robert Sabat; Ellen Witte-Händel; Kamran Ghoreschi; Kerstin Wolk
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.